| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.08 |